Benefit of Left Atrial Roof Ablation in Paroxysmal Atrial Fibrillation

Drug-refractory Paroxysmal Atrial Fibrillation Clinical Trial

Status Completed

Clinical Trial Summary

The aim of the present study is to assess whether left atrial roof ablation adds any benefit in the arrhythmia-free probability after paroxysmal atrial fibrillation ablation.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Atrial Fibrillation
• Drug-refractory Paroxysmal Atrial Fibrillation

• NCT number: NCT01203241
• Study type: Interventional
• Source: Hospital Clinic of Barcelona
• Status: Completed
• Phase: Phase 3
• Start date: June 2009
• Completion date: December 2012